Immunization Reminder Bracelets Study
The Effect of Using Vaccine Reminder and Tracker Bracelets to Improve Routine Childhood Immunization Coverage and Timeliness in Pakistan: a Randomized Control Trial.
1 other identifier
interventional
1,445
1 country
4
Brief Summary
Pakistan has one of the highest infant mortality rates in the world in part, due to the low coverage (54%) for all basic vaccinations. Low uptake, lack of awareness among parents to complete the recommended immunization schedule and inability to remember vaccine appointments are some of the key factors hindering improvement in uptake of immunization services. On the supply side, ineffective methods to track children's' vaccine doses means that there is no reliable mechanism to verify vaccine administration and estimate accurate immunization coverage. This study proposes to develop and test two types of silicon bracelets for children to stimulate immunization demand and simultaneously address supply side verification issues. These bracelets use a combination of numbers and symbols to denote the age of the child and due vaccines and are designed for illiterate or uneducated mothers; are low-cost and adaptable to most local settings. At the time of vaccine administration, the appropriate symbol denoting the vaccine on the bracelets is punched and therefore the bracelets can serve as effective reminders for mothers for timely immunization of their child and as a tool for vaccinators to verify vaccine administration and coverage. An individually randomized, three-arm parallel group design randomized control trial will be conducted with equal allocation in the two treatment groups and control group. Children in intervention group A will receive the simple silicon bracelets, children in intervention group B will receive the bracelets developed by Alma Sana Inc. and children in the Control group will not receive any intervention. The impact of these immunization reminder bracelets on immunization coverage and timeliness will be evaluated through a randomized control trial (RCT) across 4 immunization centers in Karachi. To evaluate the bracelets' impact, variables of interest-coverage and timeliness rates of pentavalent-3/PCV-3/polio-3 and Measles 1 vaccine will be compared between Group A and the Control Group and Group B and the Control Group. Proposed results include increase in immunization coverage and timeliness of Pentavalent-3/Pneumococcal Conjugate Vaccine (PCV-3)/Polio-3 and Measles-1 in the intervention versus control group. The study will provide evidence of the bracelet's effectiveness for the global health community and provide a simple tool for strengthening routine immunization efforts in Pakistan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2017
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 19, 2017
CompletedFirst Submitted
Initial submission to the registry
September 22, 2017
CompletedFirst Posted
Study publicly available on registry
October 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2018
CompletedFebruary 19, 2019
February 1, 2019
1.2 years
September 22, 2017
February 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Increase in immunization coverage in intervention versus control
The primary outcome measure is the increase in coverage (i.e. the proportion of children getting vaccinated for) Pentavalent-3/PCV-3/polio-3 and Measles 1 vaccine in intervention versus control arm.
The outcome will be measured after at least 9 months of follow up of the last participant enrolled
Increase in timeliness of immunization in intervention versus control
The primary outcome measure is the increase in timeliness of Pentavalent-3/PCV-3/polio-3 and Measles 1 vaccine in intervention versus control arm. Timeliness is defined as the proportion of children getting vaccinated for a particular antigen within the specified time duration i.e. a timely dose of Pentavalent-3/PCV-3/polio-3 is administered when the child is between 14 weeks and 22 weeks of age.
The outcome will be measured after at least 9 months of follow up of the last participant enrolled
Secondary Outcomes (1)
Comparison of timely immunization coverage rates between treatment groups
The outcome will be measured after at least 9 months of follow up of the last participant enrolled
Study Arms (3)
Alma Sana Bracelet Arm
EXPERIMENTALSubjects in this arm will receive a vaccine reminder and tracker bracelet developed by Alma Sana Inc. This bracelet uses a combination of symbols and numbers to denote the entire vaccine schedule a child is supposed to receive before the age of 2 years. Shapes indicate vaccines, and numbers signify the child's age.
Simple Silicon Bracelet Arm
EXPERIMENTALSubjects in this arm will receive a simple silicon bracelet. This bracelet has six symbols to remind parents that their child needs to get at least six vaccination visits before he reaches 2 years of age. The first five symbols are represented by a crescent shape and the sixth symbol is represented by a star shape to denote that the child is fully immunized.
Control Arm
NO INTERVENTIONSubjects in this arm will not receive any bracelet/intervention.
Interventions
Every time a child receives a vaccine, vaccinators will hole punchers to perforate shapes denoting the particular vaccine a child has received.
Every time a child receives a vaccine, vaccinators will hole punchers to perforate shapes denoting the particular vaccine a child has received.
Eligibility Criteria
You may qualify if:
- Child is visiting the center for BCG or Pentavalent-1/Polio-1/PCV-1 vaccination.
- Child is healthy
- Child's caregiver has been a resident of study area for more than 6 months
- Child is accompanied by a primary caregiver (mother and/or father)
You may not qualify if:
- Child's age is more than 3 months. The average age of children for Penta-1 vaccine visit in Pakistan is 2.2 months (approximately 10 weeks). Children older than 3 weeks will be excluded on account of exceeding the average age for Penta-1 administration.
- Parents plan to go to a different center for completing the vaccination course
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Future Colony
Karachi, Sindh, Pakistan
KMC Maternity Home
Karachi, Sindh, Pakistan
MCH-36B
Karachi, Sindh, Pakistan
Urban Health Center
Karachi, Sindh, Pakistan
Related Publications (2)
Siddiqi DA, Ali RF, Munir M, Shah MT, Khan AJ, Chandir S. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan (2017-18): a randomized controlled trial. BMC Public Health. 2020 Jul 11;20(1):1086. doi: 10.1186/s12889-020-09088-4.
PMID: 32652969DERIVEDSiddiqi DA, Munir M, Shah MT, Khan AJ, Chandir S. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan: protocol for a randomized controlled trial. BMC Public Health. 2019 Oct 30;19(1):1421. doi: 10.1186/s12889-019-7667-3.
PMID: 31666039DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Danya A Siddiqi, MSc
Interactive Research and Development
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The allocation sequence will be concealed from the study staff responsible for screening and enrolling participants in serially numbered, opaque, sealed envelopes.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Program Manager
Study Record Dates
First Submitted
September 22, 2017
First Posted
October 16, 2017
Study Start
July 19, 2017
Primary Completion
October 16, 2018
Study Completion
October 31, 2018
Last Updated
February 19, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share